top of page

This site was designed with the

website builder. Create your website today.Start Now

서울대학교 대학원 의과학과

Department of Biomedical Sciences

정밀분자종양학 연구실

Laboratory of Precision and Molecular Oncology

실제 작동 상태를 확인하려면 라이브 사이트로 이동하세요.

2022년 1월 07일

수정: 2022년 1월 07일

[Cancer Lett. 2021] Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorecta

게시판: Publications

Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers.

Oh Y, Jung HR, Min S, Kang J, Jang D, Shin S, Kim J, Lee SE, Sung CO, Lee WS, Lee C, Jeong EM, Cho SY.

Cancer Lett. 2021 Jan 28;497:123-136. doi: 10.1016/j.canlet.2020.10.018. Epub 2020 Oct 15.PMID: 33068701

https://pubmed.ncbi.nlm.nih.gov/33068701/

댓글 0개

댓글(0)

bottom of page